The Intermountain Healthcare Heart Institute research team are presenting or involved in 20 posters and abstracts at the American Heart Association’s Scientific Sessions in Philadelphia, Nov. 16-18, 2019. Topics range from heart health and intermittent fasting to precision medicine in cardiology. Our cardiovascular researchers are also serving as panelists or giving presentations focused on improving patient care.
hand-tablet-graph

Abstracts and Posters

  • COLLABORATIVE POSTER: Clinical Value of Neutrophil to Lymphocyte Ratio and its Trajectory in Patients Hospitalized with Acute Heart Failure and Preserved Ejection Fraction (Kirk U. Knowlton, MD)
  • POSTER: Evaluation of Treatment with Angiotensin Converting Enzyme Inhibitors (ACEIs) and the Risk of Lung Cancer (ERACER) (Jeffrey L. Anderson, MD)
  • POSTER: Use of the AHA Pegasis Pipeline to Identify Genetic Associations with Severe 3-Vessel Coronary Artery Disease in High-Risk Pedigrees Free from Myocardial Infarction: The ProGENE Study (Stacey Knight, PhD)
  • COLLABORATIVE ORAL POSTER: Intermittent Fasting Lifestyle and Incidence of Heart Failure and Myocardial Infarction in Cardiac Catheterization Patients (Benjamin Horne, PhD)
  • POSTER: Predictive Ability of Machine Learning Models for High-Grade Coronary Artery Disease Using Free Fatty-Acid Metabolites (Raymond O. McCubrey, MD)
  • COLLABORATIVE POSTER: Precision Cardiovascular Medicine: A Rapid and Highly Sensitive Artificial Intelligence-based Integrated Genetic-Epigenetic DNA Test for 3-Year Risk for Incident Coronary Heart Disease (Stacey Knight, PhD)
  • POSTER: Intermittent Fasting Lifestyle and Human Longevity in Cardiac Catherization Populations (Benjamin Horne, PhD)
  • POSTER: The HyperK Score is a Powerful Predictor of Incident Hyperkalemia in a Large General Healthcare Population (Heidi T. May, PhD)
  • MODERATED POSTER: Comparative 5-year Outcomes in Non-ischemic Dilated Cardiomyopathy (NIDC) Patients with TITIN (TTN) Gene Truncating Variant (tv) Mutations (Jeffrey L. Anderson, MD)
  • POSTER: Long-Term Outcomes in Patients Treated with Flecainide for Premature Ventricular Contractions or Ventricular Tachycardia with Stable Coronary Artery Disease (T. Jared Bunch, MD)
  • POSTER: Long-Term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Severe Coronary Artery Disease Treated with Revascularization (T. Jared Bunch, MD)
  • POSTER: Laboratory-based Intermountain Risk Score Compared to the Charlson and Elixhauser Comorbidity Indices for Mortality Prediction (Benjamin Horne, PhD)
  • POSTER: Use of Precision Behavioral Nudges to Modify Patient Choice Architecture: The ImprovEment in MedicatioN AdherenCe ThrOUgh the Implementation of PeRsonAlized NudGEs (ENCOURAGE) Randomized Controlled Trial (Benjamin Horne, PhD)
  • POSTER: Higher Plasma EPA, EPA/AA and DHA Levels are Associated with Lower Incident MACE in Those with and without Angiographic CAD (Viet Le, APP)
  • POSTER: Does Supplementation to Higher Plasma Omega-3 Levels Predispose to Prostate Cancer? Results from the Intermountain INSPIRE Biobank Registry (Jeffrey L. Anderson, MD)
  • POSTER: Skewness but Not Kurtosis of Red Cell Corpuscular Volume Nullifies the Predictive Ability of Red Cell Distribution Width for Predicting All-Cause Mortality (Benjamin Horne, PhD)
  • ORAL ABSTRACT: Temporal Changes in Statin Prescription, Intensity at Discharge, and Impact on Outcomes in Patients with Newly Diagnosed Atherosclerotic Peripheral Arterial Disease (PAD). A Real-World Experience within a Large Integrated Health Care System: The IMPRESS Study (Jeffrey L. Anderson, MD)
  • PRESENTATION: Catheter Ablation and Brain Injury: Implications for Dementia Prevention (T. Jared Bunch, MD)
  • PRESENTATION: AF and Dementia: Potential Mechanisms and Implications for Prevention (T. Jared Bunch, MD)
  • ORAL ABSTRACT: Long-Term Outcomes in Patients with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease (T. Jared Bunch, MD)
  • POSTER: Frequency and Clinical Impact of Hyperkalemia within a Large General Population of Heart Failure Patients (J. Brent Muhlestein, MD)
  • POSTER: Difference in Primary Prevention Recommendations for Statin Theraphy Based on National Guidelines Using the Pooled Cohort Equation Risk Versus the Coronary Artery Calcium Score: Preliminary Findings from the Vanguard Study for the CorCal Randomized Clinical Outcomes Trial (J. Brent Muhlestein, MD)
More